Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 6:23 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,538,814 5.02% | 42,289 (+2.83%) | View |
| 2022-02-11 4:11 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,282,912 10.72% | -166,000 (-4.81%) | View |
| 2021-10-25 06:07 am Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | TAKEDA PHARMACEUTICAL CO LTD TAK | 530,562 1.7% | -1,328,589 (-71.46%) | View |
| 2021-08-24 4:32 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 8% | 0 (Unchanged) | View |
| 2021-02-16 4:32 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,496,525 5.08% | 251,525 (+20.20%) | View |
| 2021-01-27 06:02 am Unchanged | 13G | MIRUM PHARMACEUTICALS INC MIRM | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,859,151 7.2% | 0 (Unchanged) | View |
| 2020-12-22 4:01 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | RiverVest Venture Fund IV L.P. | 1,921,118 6.6% | 0 (Unchanged) | View |
| 2020-12-18 4:31 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 8.4% | 0 (Unchanged) | View |
| 2020-12-18 12:40 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,566,912 12.2% | 0 (Unchanged) | View |
| 2020-04-29 4:36 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,566,912 14% | 0 (Unchanged) | View |
| 2020-02-14 1:49 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,245,000 5.42% | -155,000 (-11.07%) | View |
| 2020-02-13 12:35 pm Unchanged | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,448,912 15% | 0 (Unchanged) | View |
| 2020-01-17 1:34 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 9.63% | 0 (Unchanged) | View |
| 2019-12-16 1:00 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,400,000 6.09% | 1,400,000 (New Position) | View |
| 2019-09-10 06:21 am Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,859,151 8.1% | 1,859,151 (New Position) | View |
| 2019-08-01 10:48 am Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | RiverVest Venture Fund IV L.P. | 1,921,118 8.4% | 1,921,118 (New Position) | View |
| 2019-07-30 3:08 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | New Enterprise Associates 16 L.P. | 4,186,243 18.2% | 4,186,243 (New Position) | View |
| 2019-07-26 4:40 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,566,912 15.5% | 3,566,912 (New Position) | View |
| 2019-07-24 2:21 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,448,912 14.98% | 3,448,912 (New Position) | View |
| 2019-07-23 4:46 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 10.62% | 2,445,147 (New Position) | View |